250 related articles for article (PubMed ID: 23254634)
1. Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease.
Kim B; Backus C; Oh S; Feldman EL
J Alzheimers Dis; 2013; 34(3):727-39. PubMed ID: 23254634
[TBL] [Abstract][Full Text] [Related]
2. Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes.
Kim B; Backus C; Oh S; Hayes JM; Feldman EL
Endocrinology; 2009 Dec; 150(12):5294-301. PubMed ID: 19819959
[TBL] [Abstract][Full Text] [Related]
3. Tau hyperphosphorylation in the brain of ob/ob mice is due to hypothermia: Importance of thermoregulation in linking diabetes and Alzheimer's disease.
Gratuze M; El Khoury NB; Turgeon A; Julien C; Marcouiller F; Morin F; Whittington RA; Marette A; Calon F; Planel E
Neurobiol Dis; 2017 Feb; 98():1-8. PubMed ID: 27793638
[TBL] [Abstract][Full Text] [Related]
4. Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology.
Gratuze M; Julien J; Petry FR; Morin F; Planel E
Sci Rep; 2017 Apr; 7():46359. PubMed ID: 28402338
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
[TBL] [Abstract][Full Text] [Related]
6. Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice.
Li J; Deng J; Sheng W; Zuo Z
Pharmacol Biochem Behav; 2012 Jun; 101(4):564-74. PubMed ID: 22425595
[TBL] [Abstract][Full Text] [Related]
7. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.
Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E
Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426
[TBL] [Abstract][Full Text] [Related]
8. Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats.
Xu W; Liu J; Ma D; Yuan G; Lu Y; Yang Y
PLoS One; 2017; 12(2):e0172477. PubMed ID: 28225806
[TBL] [Abstract][Full Text] [Related]
9. Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease.
Ke YD; Delerue F; Gladbach A; Götz J; Ittner LM
PLoS One; 2009 Nov; 4(11):e7917. PubMed ID: 19936237
[TBL] [Abstract][Full Text] [Related]
10. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
[TBL] [Abstract][Full Text] [Related]
11. The role of caspase cleavage of tau in Alzheimer disease neuropathology.
Cotman CW; Poon WW; Rissman RA; Blurton-Jones M
J Neuropathol Exp Neurol; 2005 Feb; 64(2):104-12. PubMed ID: 15751224
[TBL] [Abstract][Full Text] [Related]
12. Diabetes Promotes Development of Alzheimer's Disease Through Suppression of Autophagy.
Miao Y; Guo D; Li W; Zhong Y
J Alzheimers Dis; 2019; 69(1):289-296. PubMed ID: 30958383
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone reduces tau phosphorylation via JNK inhibition in the hippocampus of rats with type 2 diabetes and tau transfected SH-SY5Y cells.
Yoon SY; Park JS; Choi JE; Choi JM; Lee WJ; Kim SW; Kim DH
Neurobiol Dis; 2010 Nov; 40(2):449-55. PubMed ID: 20655383
[TBL] [Abstract][Full Text] [Related]
14. High-Fat Diet-Induced Diabetic Conditions Exacerbate Cognitive Impairment in a Mouse Model of Alzheimer's Disease Via a Specific Tau Phosphorylation Pattern.
Ito Y; Takeda S; Nakajima T; Oyama A; Takeshita H; Miki K; Takami Y; Takeya Y; Shimamura M; Rakugi H; Morishita R
J Prev Alzheimers Dis; 2024; 11(1):138-148. PubMed ID: 38230726
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-β and tau pathology of Alzheimer's disease induced by diabetes in a rabbit animal model.
Bitel CL; Kasinathan C; Kaswala RH; Klein WL; Frederikse PH
J Alzheimers Dis; 2012; 32(2):291-305. PubMed ID: 22785400
[TBL] [Abstract][Full Text] [Related]
16. Combined vildagliptin and memantine treatment downregulates expression of amyloid precursor protein, and total and phosphorylated tau in a rat model of combined Alzheimer's disease and type 2 diabetes.
Khalaf SS; Hafez MM; Mehanna ET; Mesbah NM; Abo-Elmatty DM
Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):685-695. PubMed ID: 30759264
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of protein phosphatase 2A and hyperphosphorylation of τ protein following onset of diabetes in NOD mice.
Papon MA; El Khoury NB; Marcouiller F; Julien C; Morin F; Bretteville A; Petry FR; Gaudreau S; Amrani A; Mathews PM; Hébert SS; Planel E
Diabetes; 2013 Feb; 62(2):609-17. PubMed ID: 22961084
[TBL] [Abstract][Full Text] [Related]
18. High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status.
Takalo M; Haapasalo A; Martiskainen H; Kurkinen KM; Koivisto H; Miettinen P; Khandelwal VK; Kemppainen S; Kaminska D; Mäkinen P; Leinonen V; Pihlajamäki J; Soininen H; Laakso M; Tanila H; Hiltunen M
J Nutr Biochem; 2014 Jun; 25(6):634-41. PubMed ID: 24746833
[TBL] [Abstract][Full Text] [Related]
19. mTOR and tau phosphorylated proteins in the hippocampal tissue of rats with type 2 diabetes and Alzheimer's disease.
Ma YQ; Wu DK; Liu JK
Mol Med Rep; 2013 Feb; 7(2):623-7. PubMed ID: 23165862
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease.
Li SQ; Yu Y; Han JZ; Wang D; Liu J; Qian F; Fan GH; Bucala R; Ye RD
J Neuroinflammation; 2015 Sep; 12():177. PubMed ID: 26382037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
